Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,181.0
-17.6 (-0.55%)

 

  • STI Straits Times Index
    3,181.0
    -17.6 (-0.55%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,531.2
    -3.8 (-0.25%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,308.8
    -300.3 (-1.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,039.7
    9.5 (0.31%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,386.7
    -92.4 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,882.3
    -60.2 (-1.01%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,078.9M
  • Value: 1,171.0M
  • Rise: 88
  • Fall: 225
  • Unch: 501

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AusGroup^0.048-0.004
Rex Intl0.193-0.007
Ntegrator Intl0.008-0.002
Medtecs Intl0.097+0.001
Ley Choon0.019+0.001
YZJ Shipbldg SGD1.040-
Singtel3.100-0.030
ComfortDelGro2.020-0.030
Genting Sing0.880-
Dyna-Mac0.134-0.016

World Indices

World Indices
Name Last Change
Nasdaq 9,751.0 -66.2
HSI 27,308.8 -300.4
HSCEI 10,790.8 -123.1
Jakarta 5,882.3 -60.2
Nikkei 225 23,386.7 -92.4
SSE Comp 3,039.7 +9.5
Shanghai A 3,185.3 +10.0
Shanghai B 244.9 +0.8
KOSPI 2,162.8 -32.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

HUAKANG BIOMED HUAKANG BIOMED
Quotes 15 Minutes Delayed. Updated at 21 Feb 2020 16:08
Last (HKD): 0.134 Change: +0.002 High: 0.134 Remarks: -
Change (%): +1.52 Low: 0.133
Open 0.133 Yesterday's Close 0.132
Buy Price 0.134 Sell Price 0.145
Buy Volume ('000) 200 Sell Volume ('000) 80
Cumulative Volume ('000) 8 Cumulative Value 1,064
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -0.00136 Trailing EPS (HKD) e -0.00136 NAV (HKD) b 0.2026
PE a - Trailing PE f - Price / NAV b 0.6614
Dividend (HKD) d - Cash In Hand (HKD) g 0.1310 Issued & Paid-up Shares c 400,000,000
Dividend Yield (%) d - Price / Cash In Hand g 1.023 Treasury Shares h -
Beta - 75 Daysi -1.963 R-Squared - 75 Days(%)i 5.46 Market Cap (M) 53.600
Beta - 500 Daysi -0.378 R-Squared - 500 Days (%)i 0.38 Enterprise Value (M) 1.464
Piotroski F Score 6 Exchange Code 8622 Par Value ( HKD ) 0.01000
52 Weeks Volatility (%) 63.73 6-Month VWAP 0.192 Free Float (%) 31.0
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 Dec 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 07 Dec 2018.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference HUAKANG BIOMED HKEx 53.600 - - 0.6614 -
Industry Medical Specialties HKEx 6,915.057 46.959 33.304 2.6376 0.669
Local Peer WEIGAO GROUP HKEx 45,223.300 25.922 22.354 2.5699 1.140
Local Peer AK MEDICAL HKEx 16,001.040 93.206 68.453 14.7458 0.228
Local Peer MICROPORT HKEx 14,969.591 79.871 29.086 3.8449 0.310
Local Peer VENUS MEDTECH-B HKEx 8,185.632 - - - -
Local Peer CIRC HKEx 7,037.246 18.397 17.328 1.7360 1.403
Local Peer LIFETECH SCI HKEx 6,555.176 45.701 38.978 4.2281 -
Local Peer YESTAR HEALTH HKEx 3,259.243 10.931 10.295 2.4245 -
Local Peer GOLDEN MEDITECH HKEx 2,275.205 - - 0.5546 -
Local Peer PW MEDTECH HKEx 1,977.255 14.540 12.631 0.3811 -
Local Peer KDL MEDICAL HKEx 1,835.400 - - - -
Local Peer MODERN DENTAL HKEx 1,406.226 16.468 13.159 0.6950 2.320
Local Peer YUNNAN ENERGY HKEx 751.943 - - 2.6551 -
Other Local Peers KELFRED (HKEx), VINCENT MED (HKEx), LIFE HEALTHCARE (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 156,344.204 66.445 42.589 - 1.303
Global Peer MEDTRONIC PLC NYSE 152,615.667 32.955 28.714 2.9458 1.827
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 134,757.035 45.867 36.460 4.5411 0.218
Global Peer DANAHER CORP NYSE 111,460.830 42.046 37.914 3.8876 0.403
Global Peer STRYKER CORP NYSE 84,080.850 23.665 40.365 6.5652 0.859
Global Peer INTUITIVE SURGICAL INC NASDAQ 71,711.747 63.580 51.991 8.6778 -
Global Peer BECTON DICKINSON & CO NYSE 68,731.509 - 92.010 3.2421 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 59,237.350 35.450 12.604 - -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 48,786.609 67.553 46.601 11.7607 -
Global Peer BAXTER INTERNATIONAL INC NYSE 47,512.341 29.256 30.033 6.0820 0.788
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), DEXCOM INC (NASDAQ), RESMED INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), WATERS CORP (NYSE), HOLOGIC INC (NASDAQ), INSULET CORPORATION (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), DENTSPLY SIRONA INC (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), MASIMO CORPORATION (NASDAQ), COCHLEAR LTD (ASX), NOVOCURE LTD (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), NEVRO CORP (NYSE), NUVASIVE INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), LIVANOVA PLC (NASDAQ), QUIDEL CORP (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), CANTEL MEDICAL CORP (NYSE), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), IRHYTHM TECHNOLOGIES INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), BIOTELEMETRY INC (NASDAQ), ATRICURE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AVANOS MEDICAL INC (NYSE), SILK ROAD MEDICAL INC (NASDAQ), NANOSONICS LIMITED (ASX), INMODE LTD (NASDAQ), ATRION CORP (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CAREDX INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CRYOLIFE INC (NYSE), INOGEN INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CERUS CORP (NASDAQ), VERICEL CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), HESKA CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), AXOGEN INC (NASDAQ), QUOTIENT LTD (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), SI BONE INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), SURMODICS INC (NASDAQ), SUPERMX (Bursa), VIEWRAY INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), ANGIODYNAMICS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), CUTERA INC (NASDAQ), CORMEDIX INC (NYSE American), ORASURE TECHNOLOGIES INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), ZYNEX INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), IRADIMED CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), INVACARE CORP (NYSE), MISONIX INC (NASDAQ), STEREOTAXIS INC (NYSE American), SIENTRA INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), PROFOUND MED CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), VENUS CONCEPT INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SOLITON INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), TELA BIO INC (NASDAQ), VAPOTHERM INC (NYSE), DERMTECH INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INTRICOM CORP (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SOMNOMED LIMITED (ASX), FONAR CORP (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), RESAPP HEALTH LIMITED (ASX), PAVMED INC (NASDAQ), ELECTROMED INC (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), COMPUMEDICS (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), ONCOCYTE CORP (NYSE American), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), NEPHROS INC (NASDAQ), SDI LTD (ASX), ALPHA PRO TECH (NYSE American), ELLEX MEDICAL LASERS LTD (ASX), CONFORMIS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEURONETICS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), CYCLOPHARM LIMITED (ASX), MOTUS GI HOLDINGS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), IRIDEX CORP (NASDAQ), Medtecs Intl (SGX), Biolidics (SGX), CELLDEX THERAPEUTICS INC (NASDAQ), DAXOR CORP (NYSE American), EMVISION MEDICAL DEVICES LTD (ASX), IMMUCELL CORP (NASDAQ), IMPEDIMED LIMITED (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), UG Healthcare (SGX), EKSO BIONICS HOLDINGS INC (NASDAQ), ELECTROCORE INC (NASDAQ), CELSION CORPORATION (NASDAQ), Yunnan Energy (SGX), RESPIRI LTD (ASX), NEOVASC INC (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), MICRO-X LTD (ASX), BIOMERICA INC (NASDAQ), USCOM LTD (ASX), NANOVIBRONIX INC (NASDAQ), BIOLASE INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), LBT INNOVATIONS LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), XTANT MEDICAL HLDGS INC (NYSE American), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), DIMERIX LTD (ASX), DARIOHEALTH CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), LKL (Bursa), NEUROTROPE INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), ENDOLOGIX INC (NASDAQ), CHECK-CAP LTD (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), CARDIEX LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), Annica (SGX), MYOS RENS TECHNOLOGY INC (NASDAQ), CANCER GENETICS INC (NASDAQ), AVINGER INC (NASDAQ), ADHERIUM LIMITED (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), OPTISCAN IMAGING (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), MICRON SOLUTIONS INC (NYSE American), INSPIREMD INC (NYSE American), TENAX THERAPEUTICS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DIGIRAD CORP (NASDAQ), ANALYTICA (ASX), VIVEVE MEDICAL INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), STHAI (SET), NEUROMETRIX INC (NASDAQ), DORSAVI LTD (ASX), CHF SOLUTIONS INC (NASDAQ), METALICITY LIMITED (ASX), MEDIGARD LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.010
-6.94 %
10 Days --0.013
-8.84 %
20 Days --0.001
-0.74 %
Medium Term Return 3 Months -+0.005
+3.88 %
6 Months --0.006
-4.29 %
1 Year --0.181
-57.46 %
Annualised Return Annualised --
-57.46 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.093 - 0.380 Change From 1 Year Low +0.041 % Change From 1 Year Low (%) +44.09
Change From 1 Year High -0.246 % Change From 1 Year High (%) -64.74
2 Years Range 0.093 - 0.540 Change From 2 Years Low +0.041 % Change From 2 Years Low (%) +44.09
Change From 2 Years High -0.406 % Change From 2 Years High (%) -75.19
5 Years Range 0.093 - 0.540 Change From 5 Years Low +0.041 % Change From 5 Years Low (%) +44.09
Change From 5 Years High -0.406 % Change From 5 Years High (%) -75.19
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Huakang Biomedical Holdings Co. Ltd. operates as a medical group that focuses on research and development, manufacturing and sales of in-vitro diagnostic (IVD) reagents in China. Its product portfolio of IVD reagents comprises male fertility IVD reagents, parasite antibody detection reagents, and an EBV antibody detection reagent. The company was founded on August 3, 2017 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Feb 2020 0.133 0.134 0.133 0.134 8,000 0.1330
20 Feb 2020 0.138 0.141 0.130 0.132 1,160,000 0.1331
19 Feb 2020 0.139 0.139 0.139 0.139 16,000 0.1390
18 Feb 2020 0.139 0.140 0.139 0.140 8,000 0.1390
17 Feb 2020 0.139 0.139 0.139 0.139 216,000 0.1390
14 Feb 2020 0.138 0.139 0.138 0.139 232,000 0.1380
13 Feb 2020 0.139 0.144 0.138 0.144 968,000 0.1404
12 Feb 2020 0.138 0.145 0.138 0.143 544,000 0.1393
11 Feb 2020 0.149 0.150 0.140 0.144 1,008,000 0.1431
10 Feb 2020 0.144 0.145 0.136 0.145 2,224,000 0.1413
07 Feb 2020 0.147 0.147 0.133 0.145 1,536,000 0.1378
06 Feb 2020 0.141 0.151 0.139 0.147 2,072,000 0.1433
05 Feb 2020 0.146 0.153 0.140 0.143 2,272,000 0.1446
04 Feb 2020 0.137 0.166 0.136 0.155 4,080,000 0.1531
03 Feb 2020 0.170 0.177 0.135 0.149 10,680,000 0.1446
31 Jan 2020 0.270 0.360 0.167 0.178 26,304,000 0.2499
30 Jan 2020 0.200 0.290 0.188 0.280 59,208,000 0.2454
29 Jan 2020 0.134 0.200 0.134 0.182 9,112,000 0.1793
24 Jan 2020 0.135 0.141 0.133 0.141 240,000 0.1333
23 Jan 2020 0.136 0.150 0.134 0.135 728,000 0.1533
22 Jan 2020 0.144 0.144 0.135 0.142 488,000 0.1393
21 Jan 2020 0.142 0.144 0.136 0.144 512,000 0.1378
Summary
Current 2 Weeks
(10 Feb 2020 to 21 Feb 2020)
0.144 0.150 0.130 0.134 6,384,000 -
Previous 2 Weeks
(23 Jan 2020 to 07 Feb 2020)
0.136 0.150 0.130 0.145 116,232,000 -
4 Weeks from
(23 Dec 2019 to 22 Jan 2020)
0.145 0.160 0.130 0.142 7,208,000 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.